XINTAI, SHANDONG, CHINA, January 19, 2026 /EINPresswire.com/ -- In recent years, the global pharmaceutical packaging ...
Driven by breakthroughs in filter media and innovative technologies for injectables, vaccines, APIs, and advanced therapies, ...
Nirmala Sitharaman’s Biopharma SHAKTI announcement in the Union Budget has worked as a booster for the biotechnology sector ...
Xeris Biopharma is showing strong growth and improving EBITDA, especially driven by its blockbuster drug Recorlev. Learn why ...
Khaleej Times on MSN
Novartis deepens commitment to the UAE as pharmaceutical market set to double by 2033
The UAE is rapidly consolidating its position as a global pharmaceutical and life sciences hub, with the national market ...
A dominant position, even a monopoly, is not illegal under Trinidad and Tobago’s competition law, according to Dr Taimoon ...
1d
Top Pharmaceutical API Manufacturer Navigates Shifts in Global Drug Supply and Regulatory Landscape
According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...
ESTERO, FL / ACCESS Newswire / February 3, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the ...
Arbutus Biotech (ABUS) heads to a key March Moderna LNP patent trial as imdusiran HBV milestones drive value—get the latest ...
Industry leaders have said the Union Budget 2026 has laid the groundwork for a major shift in India's pharmaceutical sector, with the Biopharma SHAKTI initiative expected to reduce reliance on ...
Budget 2024 proposes Rs 10,000 crore investment in biopharma. Anthem Biosciences, Biocon stocks jump. Impact on pharma sector ...
Will Budget 2026’s ₹10,000 crore Biopharma Shakti plan transform India into a global biopharma manufacturing hub? Read report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results